期刊文献+

抗巨细胞病毒感染新药Letermovir研究进展

Research progress on the new drug of anti-cytomegalovirus infection:letermovir
下载PDF
导出
摘要 巨细胞病毒(Cytomegalovirus,CMV)感染在人群中很常见,在临床上通常表现轻微或无症状,但是在严重免疫功能低下的个体中,其可侵袭多个器官和系统,产生严重后果,甚至危及生命。Letermovir是一种新型非核苷类巨细胞病毒抑制剂,目前批准适应证为CMV感染和成人异基因造血干细胞移植(Hematopoietic stem cell transplantation,HSCT) CMV阳性者。本文对其药动学、药效学、药物相互作用、临床前研究、临床研究、不良反应等方面进行综述。 Cytomegalovirus( CMV) infection is common in people,which often presents mildly or asymptomatically. But in individuals with severe immunodeficiency,many organs and systems can be attacked,resulting in serious diseases and even endangering life. Letermovir is a newtype of non-nucleoside cytomegalovirus inhibitor,which is currently indicated for CM V infection and disease in adult cytomegalovirus seropositive recipients of an allogeneic hematopoietic stem cell transplantation( HSCT). This article makes a summary of the pharmacokinetics,pharmacodynamics,drugs interaction,preclinical study,clinical study and adverse effects of letermovir.
作者 李艳娇 曲晓宇 赵浩荻 宋燕青 LI Yan-jiao;QU Xiao-yu;ZHAO Hao-di;SONG Yan-qing(Department of Pharmacy,the First Hospital of Jilin University,Changchun 130021,China;College of Pharmacy,Jilin University,Changchun 130021,China)
出处 《实用药物与临床》 CAS 2018年第11期1304-1308,共5页 Practical Pharmacy and Clinical Remedies
关键词 乐特莫韦 巨细胞病毒 感染 Letermovir Cytomegalovirus Infection
  • 相关文献

参考文献1

二级参考文献92

  • 1Sarmiento JM,Dockrell DH,Schwab TR,et al.Mycophenolate mofetil increases cytomegalovirces invasive organ disease in renal transplant patients. Clinical Transplantation . 2000 被引量:2
  • 2Humar A,Snydman D.Cytomegalovirus in solid organ transplant recipients. American Journal of Transplantation . 2009 被引量:1
  • 3R R Razonable,A Rivero,A Rodriguez,et al.Allograft rejection predicts the occurrence of late-onset cytomegalovirus (CMV) disease among CMV-mismatched solid organ transplant patients receiving prophylaxis with oral ganciclovir. The Journal of Infectious Diseases . 2001 被引量:1
  • 4Razonable RR,Emery VC.Management of CMV infection and disease in transplant patients. 27-29 February 2004. Herpes . 2004 被引量:1
  • 5Razonable RR,,Paya CV.Herpesvirus infections in transplant recipients: current challenges in the clinical management of cytomegalovirus and Epstein-Barr virus infections. Herpes . 2003 被引量:1
  • 6Razonable RR,Paya CV.Infections and allograft rejection-intertwined complications of organ transplantation. Swiss Medical Weekly . 2005 被引量:1
  • 7Arthurs SK,Eid AJ,Pedersen RA,Kremers WK,Cosio FG,Patel R,Razonable RR.Delayed-onset primary cytomegalovirus disease and the risk of allograft failure and mortality after kidney transplantation. Clinical Infectious Diseases . 2008 被引量:1
  • 8Gane E,Saliba F,Valdecasas GJ,O’Grady J,Pescovitz MD,Lyman S,Robinson CA.Randomised trial of efficacy and safety of oral ganciclovir in the prevention of cytomegalovirus disease in liver-transplant recipients.The Oral Ganciclovir International Transplantation Study Group[corrected]. The Lancet . 1997 被引量:1
  • 9Fica A,Cervera C,Pérez N,Marcos MA,Ramírez J,Linares L,Soto G,Navasa M,Cofan F,Ricart MJ,Pérez-Villa F,Pu-marola T,Moreno A.Immunohistochemically proven cyto-megalovirus end-organ disease in solid organ transplant patients:clinical features and usefulness of conventional diagno stic tests. Transplant Infectious Disease . 2007 被引量:1
  • 10Razonable RR,van Cruijsen H,Brown RA,Wilson JA,Harmsen WS,Wiesner RH,Smith TF,Paya CV.Dynamics of cytomegalovirus replication during preemptive therapy with oral ganciclovir. The Journal of Infectious Diseases . 2003 被引量:1

共引文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部